Borrelia Antigens, Antibodies and Immunoassays
We now offer an extensive range of Borrelia burgdorferi antigens, antibodies and immunoassays. Our high-quality products are suitable for a range of laboratory research and vaccine development applications.
Dengue and Zika eBooks
A major challenge faced by academic researchers, pharma and public health scientists is the close structural similarity between the Dengue and Zika viruses, which continues to hamper research efforts, requiring more sensitive diagnostic tools to differentiate between them. See our resources to download your free eBook and find out more.
Using Adenoviruses to Fight Cancer
Adenoviruses are one of the major contenders for a new generation of oncolytic gene therapy vectors to treat cancer. In the second of a 2-part series, we discuss how adenoviruses are being developed as cancer therapeutics and some of the hurdles these platforms face from our own immune systems.
About The Native Antigen Company
The Native Antigen Company specialises in the development and manufacture of both native and recombinant antigens, antibodies and immunoassays for viruses and bacteria. Our antigens are used by leading pharmaceutical companies and IVD manufacturers in cutting-edge vaccine research and serology where proper folding and glycosylation are vital. As well as offering antigens from a rapidly expanding portfolio, we are increasing our range of highly specific antibodies and ELISA immunoassays. Our expertise is also available to customers on a contract basis for those needing custom protein manufacture in our proprietary mammalian cell protein expression system, together with antibody and immunoassay development.